Myocardial Infarction
|
0.010 |
Biomarker
|
disease |
BEFREE |
Thus, we conclude that VPO1 is a crucial regulator of cardiac fibrosis after MI by mediating HOCl/Smad2/3 and ERK1/2 signaling pathways, implying a promising therapeutic target in ischemic cardiomyopathy.
|
30844643 |
2019 |
Ureteral obstruction
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Our study defines the contribution of MPO, EPX, and PXDN to renal inflammation and tubulointerstitial fibrosis in the murine unilateral ureteral obstruction (UUO) model.
|
30565999 |
2019 |
Ischemic cardiomyopathy
|
0.010 |
Biomarker
|
disease |
BEFREE |
Thus, we conclude that VPO1 is a crucial regulator of cardiac fibrosis after MI by mediating HOCl/Smad2/3 and ERK1/2 signaling pathways, implying a promising therapeutic target in ischemic cardiomyopathy.
|
30844643 |
2019 |
Malignant neoplasm of prostate
|
0.010 |
Biomarker
|
disease |
BEFREE |
Therefore, PXDN may be a biomarker associated with prostate cancer and a potential therapeutic target.
|
31234468 |
2019 |
Prostate carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Therefore, PXDN may be a biomarker associated with prostate cancer and a potential therapeutic target.
|
31234468 |
2019 |
Cardiac fibrosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Thus, we conclude that VPO1 is a crucial regulator of cardiac fibrosis after MI by mediating HOCl/Smad2/3 and ERK1/2 signaling pathways, implying a promising therapeutic target in ischemic cardiomyopathy.
|
30844643 |
2019 |
Chronic Kidney Diseases
|
0.010 |
Biomarker
|
group |
BEFREE |
These findings point to EPX and PXDN as potential therapeutic targets for renal fibrosis and CKD and suggest that eosinophils modulate the response to renal injury.
|
30565999 |
2019 |
Progression of prostate cancer
|
0.010 |
Biomarker
|
disease |
BEFREE |
Overall, the data suggest that PXDN promotes progression of prostate cancer by regulating the metabolome, more specifically, by inhibiting oxidative stress leading to decreased apoptosis.
|
31234468 |
2019 |
Tubulointerstitial fibrosis
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Our study defines the contribution of MPO, EPX, and PXDN to renal inflammation and tubulointerstitial fibrosis in the murine unilateral ureteral obstruction (UUO) model.
|
30565999 |
2019 |
Vasculitis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Finally, peroxidasin-specific antibodies were also found in serum from patients with anti-MPO vasculitis and were associated with significantly more active clinical disease.
|
30279272 |
2018 |
Aortic Aneurysm, Abdominal
|
0.010 |
Biomarker
|
disease |
BEFREE |
VPO1 Modulates Vascular Smooth Muscle Cell Phenotypic Switch by Activating Extracellular Signal-regulated Kinase 1/2 (ERK 1/2) in Abdominal Aortic Aneurysms.
|
30371171 |
2018 |
Anti-Glomerular Basement Membrane Disease
|
0.010 |
Biomarker
|
disease |
BEFREE |
We determined whether autoantibodies directed against peroxidasin are also detected in GP.
|
30279272 |
2018 |
Infectious Lung Disorder
|
0.010 |
Biomarker
|
group |
BEFREE |
Deficiency of PXDN results in a failure to eradicate Pseudomonas aeruginosa and increased mortality in a murine model of Pseudomonas lung infection.
|
29775486 |
2018 |
ovarian neoplasm
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
PXDN was highly expressed in OC tissues and cells.
|
29661721 |
2018 |
Malignant neoplasm of ovary
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
PXDN was highly expressed in OC tissues and cells.
|
29661721 |
2018 |
Primary malignant neoplasm
|
0.010 |
Biomarker
|
group |
BEFREE |
PXDN is also involved in processes where epithelial-mesenchymal transition (EMT) takes place, namely fibrosis, development and cancer.
|
29305973 |
2018 |
Carcinoma, Ovarian Epithelial
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
PXDN was highly expressed in OC tissues and cells.
|
29661721 |
2018 |
Chronic Obstructive Airway Disease
|
0.010 |
Biomarker
|
disease |
BEFREE |
The NADPH oxidase-ROS-NF-κB transduction pathway, VPO1, oxidative stress and their complicated interactions are implicated in the occurrence and development of COPD combined with PH.
|
28829513 |
2017 |
early pregnancy
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
In the present study, we sought to determine whether peroxidasin and GPBP undergo dynamic regulation in the assembly of uterine tissue BMs in early pregnancy as a tractable model for dynamic adult BMs.
|
27619726 |
2017 |
melanoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Our study suggests that PXDN, NTN4 and GLIS3 play a functional role in promoting melanoma cellular invasion, and therapeutic approaches directed toward inhibiting the action of these proteins may reduce the incidence or progression of metastasis in melanoma patients.
|
27172792 |
2016 |
Neoplasm Metastasis
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Our study suggests that PXDN, NTN4 and GLIS3 play a functional role in promoting melanoma cellular invasion, and therapeutic approaches directed toward inhibiting the action of these proteins may reduce the incidence or progression of metastasis in melanoma patients.
|
27172792 |
2016 |
Diabetes
|
0.010 |
Biomarker
|
disease |
BEFREE |
Role of vascular peroxidase 1 in senescence of endothelial cells in diabetes rats.
|
26142204 |
2015 |
Diabetes Mellitus
|
0.010 |
Biomarker
|
group |
BEFREE |
Role of vascular peroxidase 1 in senescence of endothelial cells in diabetes rats.
|
26142204 |
2015 |
Bilateral microphthalmos
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
We re-examined exome data from 20 other patients with structural eye defects and identified two additional PXDN mutations in a sporadic male with bilateral microphthalmia, cataracts and anterior segment dysgenesis--a maternally inherited, frameshift mutation, c.1192delT, predicting p.(Tyr398Thrfs*40) and a paternally inherited, missense substitution that was predicted to be deleterious, c.947 A>C, predicting p.(Gln316Pro).
|
24939590 |
2015 |
Autistic Disorder
|
0.010 |
Biomarker
|
disease |
BEFREE |
Results from this study indicate that the 2p25.3 duplication disrupting PXDN and MYT1L is a potential autism-causing variant in the pedigree reported here and should receive further consideration as a candidate for autism.
|
22157634 |
2012 |